Management & Regulatory

Can Equitable Care Build a Healthier Future?
Management & Regulatory Can Equitable Care Build a Healthier Future?

In a world grappling with the compounding pressures of global conflict and environmental disasters, the very foundation of public health is being tested, revealing deep-seated inequities that threaten our collective future. The challenge is no longer merely about treating disease but about

Vendor Breach Exposes Jupiter Medical Patient Records
Management & Regulatory Vendor Breach Exposes Jupiter Medical Patient Records

The intricate web of modern healthcare technology, designed to streamline patient care, has once again demonstrated its potential vulnerability after a significant data breach at a third-party vendor exposed the sensitive records of patients from Jupiter Medical Center. The incident, which did not

Review of Wegovy 7.2mg Dose
Management & Regulatory Review of Wegovy 7.2mg Dose

For many individuals on a weight management journey, hitting a plateau can feel like an insurmountable barrier, but a new, higher dosage of a well-known medication aims to break through that very wall. This review assesses the clinical significance and therapeutic value of the newly approved 7.2mg

Review of Nucala for COPD
Management & Regulatory Review of Nucala for COPD

The relentless cycle of flare-ups for those with severe Chronic Obstructive Pulmonary Disease has long demanded a more precise therapeutic weapon, a need the UK's health authorities have now addressed with a new approval. This review evaluates Nucala (mepolizumab), recently authorized by the MHRA

FDA Approves Oral Wegovy Pill for Weight Loss
Management & Regulatory FDA Approves Oral Wegovy Pill for Weight Loss

With the recent FDA approval of Novo Nordisk's oral version of Wegovy, the landscape of weight management treatment is poised for a monumental shift. We sat down with biopharma expert Ivan Kairatov, whose extensive background in research and development offers a unique lens on this

Is Samsung's US Move a Game-Changer for Biopharma?
Management & Regulatory Is Samsung's US Move a Game-Changer for Biopharma?

The intricate global network that delivers life-saving medicines has proven remarkably fragile in recent years, prompting a fundamental rethinking of how and where these complex therapies are produced. In this context, Samsung Biologics' recent acquisition of a major US-based manufacturing facility

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later